Wilkins Investment Counsel Inc. Has $6.57 Million Stake in Clorox Company (The) (CLX)

Wilkins Investment Counsel Inc. lessened its position in Clorox Company (The) (NYSE:CLX) by 1.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 49,303 shares of the company’s stock after selling 550 shares during the quarter. Clorox Company (The) makes up about 2.1% of Wilkins Investment Counsel Inc.’s holdings, making the stock its 26th biggest holding. Wilkins Investment Counsel Inc.’s holdings in Clorox Company (The) were worth $6,569,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. American Beacon Advisors Inc. acquired a new position in Clorox Company (The) in the 1st quarter valued at approximately $104,000. Parkside Financial Bank & Trust increased its stake in Clorox Company (The) by 3.8% in the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares during the period. Valley National Advisers Inc. increased its stake in Clorox Company (The) by 0.6% in the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. increased its stake in Clorox Company (The) by 0.7% in the 1st quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares during the period. Finally, Zions Bancorporation increased its stake in Clorox Company (The) by 5.6% in the 1st quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after buying an additional 53 shares during the period. Institutional investors and hedge funds own 71.24% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Wilkins Investment Counsel Inc. Has $6.57 Million Stake in Clorox Company (The) (CLX)” was posted by BBNS and is owned by of BBNS. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://baseballnewssource.com/markets/clorox-company-the-clx-stake-lowered-by-wilkins-investment-counsel-inc/1604965.html.

Shares of Clorox Company (NYSE:CLX) opened at 129.83 on Friday. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The firm has a market cap of $16.76 billion, a PE ratio of 24.34 and a beta of 0.40. The firm has a 50-day moving average of $136.15 and a 200 day moving average of $135.22.

Clorox Company (The) (NYSE:CLX) last posted its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter in the prior year, the company earned $1.30 earnings per share. Clorox Company (The)’s revenue was up 2.9% on a year-over-year basis. On average, equities analysts predict that Clorox Company will post $5.66 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s payout ratio is 63.04%.

In related news, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jon M. Balousek sold 9,223 shares of the stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the sale, the senior vice president now owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. In the last 90 days, insiders sold 21,242 shares of company stock valued at $2,944,449. Company insiders own 0.74% of the company’s stock.

Several research analysts have recently commented on the stock. Jefferies Group LLC reiterated a “hold” rating and issued a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a research note on Wednesday, August 9th. Royal Bank Of Canada reiterated a “hold” rating and issued a $115.00 target price on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. BMO Capital Markets set a $150.00 target price on shares of Clorox Company (The) and gave the company a “buy” rating in a research note on Thursday, August 3rd. BidaskClub upgraded shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. Finally, Zacks Investment Research lowered shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. Clorox Company (The) has a consensus rating of “Hold” and a consensus price target of $127.81.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.